ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,729, issued on Aug. 11, was assigned to Zealand Pharma A/S (Soborg, Denmark).

"GIP agonist compounds and methods" was invented by Anne Pernille Tofteng Shelton (Soborg, Denmark), Pia Norregaard (Soborg, Denmark), Maria Alexandrovna Deryabina (Soborg, Denmark), Bjarne Due Larsen (Soborg, Denmark) and Jacob Ulrik Fog (Soborg, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to acylated GIP analogues which have GIP agonist activity, and their use in the treatment of metabolic disorders."

The patent was filed on Sept. 22, 2023, under Application No. 18/371,680.

*For further information, including images, charts and ...